国药科技股份有限公司（08156）于2026年1月6日发布截至2025年12月31日的股份变动月报表。根据公告，公司注册股本总额为港币2亿，拆分为12,800,000,000股普通股及3,200,000,000股可换股优先股，面值均为每股港币0.0125。
报告期内，公司普通股实收股本数量维持在633,693,055股，可换股优先股数量稳定在1,480,151,050股，未有新的发行、购回或注销活动。与此同时，公司2021年购股权计划中部分购股权失效，数量由期初的5,440,000份减少至期末的5,280,000份。
公告显示，截至12月底，公司整体股本未发生变动。公司确认上述变动均符合香港联交所《上市规则》及相关法律法规。公告由执行董事郭淑仪签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.